Loraz and Viracept drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loraz (lorazepam) and Viracept (nelfinavir mesylate). Common drug interactions include crying among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Loraz and Viracept. It is created by eHealthMe based on reports of 61 people who take the same drugs from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.

What is Viracept?

Viracept has active ingredients of nelfinavir mesylate. It is often used in hiv infection. eHealthMe is studying from 6,399 Viracept users. Check the latest studies of Viracept.



On Jul, 19, 2026

61 people who take Loraz and Viracept together, and have interactions are studied.

Loraz and Viracept drug interactions.

What are the common drug interactions of Loraz and Viracept, by gender? *:

female:

  1. Crying
  2. Foot fracture
  3. Gait disturbance
  4. Headache (pain in head)
  5. Mobility decreased (ability to move is reduced)
  6. Suicidal ideation
  7. Abdominal distension
  8. Abdominal pain upper
  9. Alopecia (absence of hair from areas of the body)
  10. Blood pressure decreased

male:

  1. Emotional distress
  2. Pain
  3. Multiple fractures
  4. Osteonecrosis (death of bone)
  5. Osteopenia (a condition where bone mineral density is lower than normal)
  6. Pyrexia (fever)
  7. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  8. Hyperkalaemia (damage to or disease of the kidney)
  9. Tooth loss
  10. Bone loss

What are the common drug interactions of Loraz and Viracept, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Chronic kidney disease
  3. Emotional distress
  4. Pain
  5. Anaemia (lack of blood)
  6. Fatigue (feeling of tiredness)
  7. Renal failure (kidney dysfunction)
  8. Abdominal distension
  9. Akathisia (a movement disorder characterized by a feeling of inner restlessness)
  10. Asthenia (weakness)

40-49:

  1. Impaired work ability
  2. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  3. Nephrolithiasis (calculi in the kidneys)
  4. Renal impairment (severely reduced kidney function)
  5. Renal transplant
  6. Tooth loss
  7. Bone loss
  8. Hip arthroplasty
  9. Multiple fractures
  10. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)

50-59:

  1. Emotional distress
  2. Pain
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Bone density decreased
  5. Chronic kidney disease
  6. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  7. Osteopenia (a condition where bone mineral density is lower than normal)
  8. Spinal osteoarthritis (joint cartilage loss in spine)
  9. Abdominal discomfort
  10. Diarrhoea

60+:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Blood creatinine increased
  3. Heart rate decreased
  4. Hip arthroplasty
  5. Intervertebral disc degeneration (spinal disc degeneration)
  6. Intervertebral disc protrusion (spinal disc protrusion)
  7. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  8. Osteonecrosis (death of bone)
  9. Osteoporosis (bones weak and more likely to break)
  10. Pain

What are the existing conditions these people have? *

  1. Infection: 6 people, 9.84%
  2. High Blood Cholesterol: 6 people, 9.84%
  3. Procedural Pain: 4 people, 6.56%
  4. High Blood Pressure: 4 people, 6.56%
  5. Diabetes: 4 people, 6.56%
  6. Depression: 4 people, 6.56%
  7. Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 4 people, 6.56%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and Viracept?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Loraz and Viracept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Loraz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Viracept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Loraz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Viracept and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam and nelfinavir mesylate (the active ingredients of Loraz and Viracept, respectively), and Loraz and Viracept (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: